Acino International AG is a Swiss pharmaceutical company headquartered in Zurich, specializing in the development, manufacture, and international marketing of high-quality generic and specialty medicines. Established in 1836, Acino focuses on emerging markets across the Middle East, Africa, Ukraine, the CIS region, and Latin America. The company offers contract manufacturing and out-licensing services, leveraging advanced drug delivery technologies such as modified-release and dispersible formulations.